These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

405 related articles for article (PubMed ID: 33045958)

  • 1. Targeting Drugs Against Fibroblast Growth Factor(s)-Induced Cell Signaling.
    Agrawal S; Maity S; AlRaawi Z; Al-Ameer M; Kumar TKS
    Curr Drug Targets; 2021; 22(2):214-240. PubMed ID: 33045958
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The potential of fibroblast growth factor/fibroblast growth factor receptor signaling as a therapeutic target in tumor angiogenesis.
    Ronca R; Giacomini A; Rusnati M; Presta M
    Expert Opin Ther Targets; 2015; 19(10):1361-77. PubMed ID: 26125971
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Future applications of FGF/FGFR inhibitors in cancer.
    Ghedini GC; Ronca R; Presta M; Giacomini A
    Expert Rev Anticancer Ther; 2018 Sep; 18(9):861-872. PubMed ID: 29936878
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Implications of Fibroblast Growth Factors (FGFs) in Cancer: From Prognostic to Therapeutic Applications.
    Dianat-Moghadam H; Teimoori-Toolabi L
    Curr Drug Targets; 2019; 20(8):852-870. PubMed ID: 30648505
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural basis for fibroblast growth factor receptor activation.
    Mohammadi M; Olsen SK; Ibrahimi OA
    Cytokine Growth Factor Rev; 2005 Apr; 16(2):107-37. PubMed ID: 15863029
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting the fibroblast growth factor receptor family in cancer.
    Hallinan N; Finn S; Cuffe S; Rafee S; O'Byrne K; Gately K
    Cancer Treat Rev; 2016 May; 46():51-62. PubMed ID: 27109926
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of fibroblast growth factors in tumor growth.
    Korc M; Friesel RE
    Curr Cancer Drug Targets; 2009 Aug; 9(5):639-51. PubMed ID: 19508171
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacologically targeting the myristoylation of the scaffold protein FRS2α inhibits FGF/FGFR-mediated oncogenic signaling and tumor progression.
    Li Q; Alsaidan OA; Ma Y; Kim S; Liu J; Albers T; Liu K; Beharry Z; Zhao S; Wang F; Lebedyeva I; Cai H
    J Biol Chem; 2018 Apr; 293(17):6434-6448. PubMed ID: 29540482
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fibroblast Growth Factor Receptor Signaling in Skin Cancers.
    Czyz M
    Cells; 2019 Jun; 8(6):. PubMed ID: 31167513
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fibroblast growth factors, fibroblast growth factor receptors, diseases, and drugs.
    Chen GJ; Forough R
    Recent Pat Cardiovasc Drug Discov; 2006 Jun; 1(2):211-24. PubMed ID: 18221087
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FGFR a promising druggable target in cancer: Molecular biology and new drugs.
    Porta R; Borea R; Coelho A; Khan S; Araújo A; Reclusa P; Franchina T; Van Der Steen N; Van Dam P; Ferri J; Sirera R; Naing A; Hong D; Rolfo C
    Crit Rev Oncol Hematol; 2017 May; 113():256-267. PubMed ID: 28427515
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent developments and advances of FGFR as a potential target in cancer.
    Xue WJ; Li MT; Chen L; Sun LP; Li YY
    Future Med Chem; 2018 Sep; 10(17):2109-2126. PubMed ID: 30066580
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Small molecule inhibition of fibroblast growth factor receptors in cancer.
    Liang G; Chen G; Wei X; Zhao Y; Li X
    Cytokine Growth Factor Rev; 2013 Oct; 24(5):467-75. PubMed ID: 23830577
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blocking the FGF/FGFR system as a "two-compartment" antiangiogenic/antitumor approach in cancer therapy.
    Giacomini A; Chiodelli P; Matarazzo S; Rusnati M; Presta M; Ronca R
    Pharmacol Res; 2016 May; 107():172-185. PubMed ID: 27013279
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Fibroblast Growth Factor signaling pathway.
    Ornitz DM; Itoh N
    Wiley Interdiscip Rev Dev Biol; 2015; 4(3):215-66. PubMed ID: 25772309
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fibroblast growth factor receptor signaling in hereditary and neoplastic disease: biologic and clinical implications.
    Helsten T; Schwaederle M; Kurzrock R
    Cancer Metastasis Rev; 2015 Sep; 34(3):479-96. PubMed ID: 26224133
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fibroblast growth factor signaling and inhibition in non-small cell lung cancer and their role in squamous cell tumors.
    Salgia R
    Cancer Med; 2014 Jun; 3(3):681-92. PubMed ID: 24711160
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective FGFR/FGF pathway inhibitors: inhibition strategies, clinical activities, resistance mutations, and future directions.
    Repetto M; Crimini E; Giugliano F; Morganti S; Belli C; Curigliano G
    Expert Rev Clin Pharmacol; 2021 Oct; 14(10):1233-1252. PubMed ID: 34591728
    [No Abstract]   [Full Text] [Related]  

  • 19. Selectively desulfated heparin inhibits fibroblast growth factor-induced mitogenicity and angiogenesis.
    Lundin L; Larsson H; Kreuger J; Kanda S; Lindahl U; Salmivirta M; Claesson-Welsh L
    J Biol Chem; 2000 Aug; 275(32):24653-60. PubMed ID: 10816596
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of fibroblast growth factors and their receptors in prostate cancer.
    Kwabi-Addo B; Ozen M; Ittmann M
    Endocr Relat Cancer; 2004 Dec; 11(4):709-24. PubMed ID: 15613447
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.